Cargando…
The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease
Stage 4S neuroblastoma is a childhood cancer occurring in infants (<12 months at diagnosis) with metastases limited to liver, skin, and bone marrow (<10%). It is associated with an excellent outcome, due to its notable ability to undergo spontaneous regression without any therapeutic intervent...
Autores principales: | Parodi, Stefano, Ognibene, Marzia, Haupt, Riccardo, Pezzolo, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277942/ https://www.ncbi.nlm.nih.gov/pubmed/32429447 http://dx.doi.org/10.3390/diagnostics10050315 |
Ejemplares similares
-
Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020) -
Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma
por: Ognibene, Marzia, et al.
Publicado: (2020) -
Neuroblastoma Patients’ Outcome and Chromosomal Instability
por: Ognibene, Marzia, et al.
Publicado: (2023) -
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers
por: Ognibene, Marzia, et al.
Publicado: (2023) -
Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4
por: Ognibene, Marzia, et al.
Publicado: (2022)